2100 POWELL STREET, EMERYVILLE, CA
Tender Offer Commenced by Samba Merger Sub for Dynavax Shares at $15.50
To Acquire, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program
Executive Transition - David Novack Moves to Senior VP Role
Investor Presentation
Reports Second Quarter 2025 Financial Results
News, Articles of Incorporation, Bylaws
Changes in Board, Management or Compensation
Q3
Q2
Q1
FY 2023
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Tender Offer Statement by Issuer
Registration of Securities
Definitive Additional Information Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
S-8 POS
Amended Schedule 14D-9 Solicitation/Recommendation Statement
Amended Tender Offer Statement by Third Party